@article {Hinderaker:2009:1027-3719:1560,title = "Serious adverse reactions in a tuberculosis programme setting in Kyrgyzstan [Notes from the field]",
journal = "The International Journal of Tuberculosis and Lung Disease",
parent_itemid = "infobike://iuatld/ijtld",
publishercode ="iuatld",
year = "2009",
volume = "13",
number = "12",
publication date ="2009-12-01T00:00:00",
pages = "1560-1562",
itemtype = "ARTICLE",
issn = "1027-3719",
eissn = "1815-7920",
url = "http://www.ingentaconnect.com/content/iuatld/ijtld/2009/00000013/00000012/art00020",
keyword = "adverse reactions, anti-tuberculosis drugs, Kyrgyzstan"
abstract = "Serious adverse reactions among new smear-positive patients were studied in a programme setting in Kyrgyzstan. Two per cent of patients on tuberculosis (TB) treatment had to interrupt treatment for 1 week, and more than 80% of the reactions occurred during the first month of treatment. Pyrazinamide was the most common causative agent, followed by rifampicin.",
author = "Hinderaker, S. G. and Ysykeeva, J. and Veen, J. and Enarson, D. A.",
}